Chemokines and leukocyte traffic

Metchnikoff, E. L'immunité dans les Maladies Infectieuses(Masson & Cie, Paris, (1901).

Baggiolini, M., Dewald, B. & Moser, B. Interleukin-8 and related chemotactic cytokines — CXC and CC chemokines. Adv. Immunol. 55, 97–179 (1994).

Baggiolini, M., Walz, A. & Kunkel, S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045–1049 (1989).

Rajarathnam, K., Clark-Lewis, I. & Sykes, B. D. 1H NMR solution structure of an active monomeric interleukin-8. Biochemistry 34, 12983& ndash;12990 (1995).

Kennedy, J.et al. Molecular cloning and functional characterization of human lymphotactin. J.Immunol. 155, 203–209 (1995).

Bazan, J. F.et al. Anew class of membrane-bound chemokine with a CX3C motif. Nature 385, 640–644 (1997).

Pan, Y.et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387, 611–617 (1997).

Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314 (1994).

Baggiolini, M., Dewald, B. & Moser, B. Human chemokines: an update. Annu. Rev. Immunol. 15, 675–705 (1997).

Furie, M. B. & Randolph, G. J. Chemokines and tissue injury. Am. J. Pathol. 146, 1287–1301 (1995).

Murphy, P. M. Chemokine receptors: structure, function and rol e in microbial pathogenesis. Cytokine Growth Fact. Rev. 7, 47–64 (1996).

Clark-Lewis, I.et al. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57, 703–711 (1995).

Zhang, Y. J., Rutledge, B. J. & Rollins, B. J. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J. Biol. Chem. 269, 15918–15924 (1994).

Simmons, G.et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276, 276–279 (1997).

Masure, S., Paemen, L., Proost, P., Van Damme, J. & Opdenakker, G. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist. J. Interferon Cytokine Res. 15, 955–963 (1995).

Crump, M. P.et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996–7007 (1997).

Heath, H.et al. Chemokine receptor usage by human eosinophils — the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99, 178–184 (1997).

D'Souza, M. P. & Harden, V. A. Chemokines and HIV-1 second receptors — confluence of two fields generates optimism in AIDS research. Nature Med. 2, 1293–1300 (1996).

Cocchi, F.et al. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811–1815 (1995).

Oberlin, E.et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–835 (1996).

Bleul, C. C.et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996).

Arenzana-Seisdedos, F.et al. HIV blocked by chemokine antagonist. Na ture 383, 400 (1996).

Baggiolini, M. & Moser, B. Blocking chemokine receptors. J. Exp. Med. 186, 1189–1191 (1997).

Strieter, R. M.et al. “The good, the bad, and the ugly”: the role of chemokines in models of human disease. J. Immunol. 156, 3583–3586 (1996).

Sekido, N.et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365, 654–657 (1993).

Nishimura, A.et al. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J. Leukocyte Biol. 62, 444–449 (1997).

Feng, L., Xia, Y., Yoshimura, T. & Wilson, C. B. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 95, 1009–1017 (1995).

Rand, M. L., Warren, J. S., Mans our, M. K., Newman, W. & Ringler, D. J. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am. J. Pathol. 148, 855–864 (1996).

Lukacs, N. W.et al. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J. Immunol. 158, 4398–4404 (1997).

Gong, J. H., Ratkay, L. G., Waterfield, J. D. & Clark-Lewis, I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186, 131–137 (1997).

Plater-Zyberk, C., Hoogewerf, A. J., Proudfoot, A. E. I., Power, C. A. & Wells, T. N. C. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57, 117–120 (1997).

Baggiolini, M. & Dahinden, C. A. CC chemokines in allergic inflammation. Immunol. Today 15, 127–133 (1994).

Uguccioni, M.et al. High expression of the chemokine receptor CCR3 in human blood basophils — role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100, 1137–1143 (1997).

Yamada, H.et al. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231, 365–368 (1997).

Sallusto, F., Mackay, C. R. & Lanzavecchia, A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277, 2005–2007 (1997).

Gerber, B. O.et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7, 836–843 (1997).

Forssmann, U.et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185, 2171–2176 (1997).

Rothenberg, M. E., MacLean, J. A., Pearlman, E., Luster, A. D. & Leder, P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185, 785–790 (1997).

Loetscher, P., Seitz, M., Baggiolini, M. & Moser, B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184, 569–577 (1996).

Bleul, C. C., Wu, L. J., Hoxie, J. A., Springer, T. A. & Mackay, C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl Acad. Sci. USA 94, 1925–1930 (1997).

Moore, J. P. & Koup, R. A. Chemoattractants attract HIV researchers. J. Exp. Med. 184, 311–313 (1996).

Loetscher, M.et al. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184, 963–969 (1996).

Abbas, A. K., Murphy, K. M. & Sher, A. F unctional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).

Loetscher, P.et al. CCR5 is characteristic for Th1 lymphocytes. Nature 391, 344–345 (1998).

Bonecchi, R.et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and TH2s. J. Exp. Med. 187, 129–134 (1998).

Sallusto, F., Lenig, D., Mackay, C. R. & Lanzavecchia, A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and T helper 2 lymphocytes. J. Exp. Med.(in the press).

Butcher, E. C. & Picker, L. J. Lymphocyte homing and homeostasis. Science 272, 60–66 (1996).

Yoshie, O., Imai, T. & Nomiyama, H. Novel lymphocyte-specific CC chemokines and their receptors. J.Leukocyte Biol. 62, 634–644 (1997).

Adema, G. J.et al. Adendritic-cell-derived C-C chemokine that preferential ly attracts naive T cells. Nature 387, 713–717 (1997).

Vicari, A. P.et al. TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7, 291–301 (1997).

Förster, R.et al. Aputative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037–1047 (1996).

Legler, D. F.et al. BCA-1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187, 655–660 (1998).

Gunn, M. D.et al. AB-cell-homing chemokine made in lymphoid follicles activated Burkitt's lymphoma receptor-1. Nature 391, 799–803 (1998).

Nagasawa, T., Kikutani, H. & Kishimoto, T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl Acad. Sci. USA 91, 2305–2309 (1994).

Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. & Springer, T. A. Ahighly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101–1109 (1996).

Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877 (1996).

Nagasawa, T.et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638 (1996).

D'Apuzzo, M.et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27, 1788–1793 (1997).

Aiuti, A., Webb, I. J., Bleul, C., Springer, T. & Gutierrez-Ramos, J. C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185, 111–120 (1997).

Hadley, T. J. & Peiper, S. C. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 89, 3077–3091 (1997).

Arenberg, D. A.et al. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J. Leukocyte Biol. 62, 554–562 (1997).

Cook, D. N. The role of MIP-1α in inflammation and hematopoiesis. J. Leukocyte Biol. 59, 61–66 (1996).

Verfaillie, C. M. Chemokines as inhibitors of hematopoietic progenitors. J. Lab. Clin. Med. 127, 148–150 (1996).

Tilton, B., Andjelkovic, M., Didichenko, S. A., Hemmings, B. A. & Thelen, M. G-protein coupled receptors and Fcg-receptors mediate activation of Akt/protein kinase B in human phagocytes. J. Biol. Chem. 272, 28096–28101 (1997).

Laudanna, C., Campbell, J. J. & Bu tcher, E. C. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 271, 981–983 (1996).

Bokoch, G. M. Chemoattractant signaling and leukocyte activation. Blood 86, 1649–1660 (1995).

Horuk, R.et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158, 2882–2890 (1997).

Roos, R. S.et al. Identification of CCR8, the receptor for the human CC chemokine I-309. J. Biol. Chem. 272, 17251–17254 (1997).

Tiffany, H. L.et al. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J. Exp. Med. 186, 165–170 (1997).